| Product Code: ETC8616034 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The import shipments of vaccine contract manufacturing to Niger in 2024 continued to be dominated by top exporting countries such as China, France, India, Benin, and Ghana. The high Herfindahl-Hirschman Index (HHI) concentration in 2023 persisted into 2024, indicating a competitive market with dominant players. Despite a significant negative growth rate from 2023 to 2024, the compound annual growth rate (CAGR) over the period of 2020-2024 remained impressive at 26.19%, reflecting the overall growth trend in the market. The market dynamics in Niger for vaccine contract manufacturing imports present both challenges and opportunities for stakeholders.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Niger Vaccine Contract Manufacturing Market Overview |
3.1 Niger Country Macro Economic Indicators |
3.2 Niger Vaccine Contract Manufacturing Market Revenues & Volume, 2021 & 2031F |
3.3 Niger Vaccine Contract Manufacturing Market - Industry Life Cycle |
3.4 Niger Vaccine Contract Manufacturing Market - Porter's Five Forces |
3.5 Niger Vaccine Contract Manufacturing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Niger Vaccine Contract Manufacturing Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Niger Vaccine Contract Manufacturing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for vaccines in Niger due to rising disease prevalence and government initiatives for immunization programs. |
4.2.2 Growth in research and development activities in the pharmaceutical industry leading to outsourcing of vaccine manufacturing. |
4.2.3 Technological advancements in vaccine manufacturing processes leading to increased efficiency and cost-effectiveness. |
4.3 Market Restraints |
4.3.1 High initial capital investment required for setting up vaccine manufacturing facilities. |
4.3.2 Stringent regulatory requirements and quality standards for vaccine production. |
4.3.3 Limited skilled workforce and expertise in vaccine manufacturing in Niger. |
5 Niger Vaccine Contract Manufacturing Market Trends |
6 Niger Vaccine Contract Manufacturing Market, By Types |
6.1 Niger Vaccine Contract Manufacturing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Niger Vaccine Contract Manufacturing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Niger Vaccine Contract Manufacturing Market Revenues & Volume, By Fill-Finish, 2021- 2031F |
6.1.4 Niger Vaccine Contract Manufacturing Market Revenues & Volume, By Bulk Product, 2021- 2031F |
6.2 Niger Vaccine Contract Manufacturing Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Niger Vaccine Contract Manufacturing Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.2.3 Niger Vaccine Contract Manufacturing Market Revenues & Volume, By Biotech Companies, 2021- 2031F |
6.2.4 Niger Vaccine Contract Manufacturing Market Revenues & Volume, By Others, 2021- 2031F |
7 Niger Vaccine Contract Manufacturing Market Import-Export Trade Statistics |
7.1 Niger Vaccine Contract Manufacturing Market Export to Major Countries |
7.2 Niger Vaccine Contract Manufacturing Market Imports from Major Countries |
8 Niger Vaccine Contract Manufacturing Market Key Performance Indicators |
8.1 Percentage increase in the number of vaccine manufacturing contracts signed in Niger. |
8.2 Average turnaround time for vaccine manufacturing projects. |
8.3 Percentage reduction in production costs per unit of vaccine. |
8.4 Number of new vaccine formulations developed and manufactured in Niger. |
8.5 Percentage improvement in production efficiency and capacity utilization rates. |
9 Niger Vaccine Contract Manufacturing Market - Opportunity Assessment |
9.1 Niger Vaccine Contract Manufacturing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Niger Vaccine Contract Manufacturing Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Niger Vaccine Contract Manufacturing Market - Competitive Landscape |
10.1 Niger Vaccine Contract Manufacturing Market Revenue Share, By Companies, 2024 |
10.2 Niger Vaccine Contract Manufacturing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |